Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,949 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Macrocyclic Peptide-Mediated Blockade of the CD47-SIRPα Interaction as a Potential Cancer Immunotherapy.
Hazama D, Yin Y, Murata Y, Matsuda M, Okamoto T, Tanaka D, Terasaka N, Zhao J, Sakamoto M, Kakuchi Y, Saito Y, Kotani T, Nishimura Y, Nakagawa A, Suga H, Matozaki T. Hazama D, et al. Among authors: nishimura y. Cell Chem Biol. 2020 Sep 17;27(9):1181-1191.e7. doi: 10.1016/j.chembiol.2020.06.008. Epub 2020 Jul 7. Cell Chem Biol. 2020. PMID: 32640189 Free article.
Crucial Role of Extracellular Vesicles in Bronchial Asthma.
Nagano T, Katsurada M, Dokuni R, Hazama D, Kiriu T, Umezawa K, Kobayashi K, Nishimura Y. Nagano T, et al. Among authors: nishimura y. Int J Mol Sci. 2019 May 27;20(10):2589. doi: 10.3390/ijms20102589. Int J Mol Sci. 2019. PMID: 31137771 Free PMC article. Review.
Novel cancer therapy targeting microbiome.
Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y. Nagano T, et al. Among authors: nishimura y. Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Onco Targets Ther. 2019. PMID: 31190864 Free PMC article. Review.
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case-Control Study.
Kiriu T, Yamamoto M, Nagano T, Hazama D, Sekiya R, Katsurada M, Katsurada N, Tachihara M, Kobayashi K, Nishimura Y. Kiriu T, et al. Among authors: nishimura y. Onco Targets Ther. 2019 Dec 2;12:10559-10568. doi: 10.2147/OTT.S228138. eCollection 2019. Onco Targets Ther. 2019. PMID: 31819535 Free PMC article.
Feasibility Study of Adjuvant Chemotherapy with Carboplatin and Nab-Paclitaxel for Completely Resected NSCLC.
Katsurada N, Tachihara M, Hatakeyama Y, Koyama K, Yumura M, Kiriu T, Dokuni R, Hazama D, Tokunaga S, Tamura D, Nakata K, Yamamoto M, Kamiryo H, Kobayashi K, Tanaka Y, Maniwa Y, Nishimura Y. Katsurada N, et al. Among authors: nishimura y. Cancer Manag Res. 2020 Feb 3;12:777-782. doi: 10.2147/CMAR.S239647. eCollection 2020. Cancer Manag Res. 2020. PMID: 32099473 Free PMC article.
3,949 results